Tracheoesophageal fistula and esophageal perforation in a patient with advanced gastroesophageal junction tumor post ramucirumab treatment. A case report and literature review

Background: Ramucirumab is an anti-angiogenic drug that received Food and Drug Administration (FDA)-approvals for treatments of many cancers. Gastrointestinal fistulas and perforations are recognized side effects of anti-angiogenic therapies, however, there are very few reported cases of these condi...

Полное описание

Библиографические подробности

Главные авторы:	Ahmed Abdalhadi, Mouhammad J Alawad, Nabil E. Omar, Muhammed Hajmusa, Mohammed Gaber, Alaaeldin Shablak
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2023-03-01
Серии:	Current Problems in Cancer: Case Reports
Предметы:	Tracheoesophageal fistula Gastroesophageal junction tumor Ramucirumab Anti-angiogenic FOLFOX GEJ
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2666621922000783
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!